The Biosimilars Group is a one-stop solution provider to realize complex biosimilar projects tailored to your specific requirements.

Berlin, Mannheim / Germany, June 02, 2016: The Biosimilars Group and CCDRD AG, a German based CRO, have today announced a partnership to bring more effort/progress in the development of biosimilars.

March 23, 2015 / The Biosimilars Group offers as a new and unique service to its clients - a one-day workshop for full biosimilar development project planning. In this workshop senior experts from The Biosimilars Group and representatives from the client's organization will develop a tailor-made project plan from start of cell-line development up to and including the first clinical study.

September 22, 2014 / This new company starts operations today and offers a complete service portfolio for the biosimilar industry including analytics driven biosimilar development, process development and manufacturing, non-clinical and clinical testing as well as regulatory and pharmacovigilance support.